Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3347627
Max Phase: Preclinical
Molecular Formula: C42H50BN5O5
Molecular Weight: 715.70
Molecule Type: Small molecule
Associated Items:
ID: ALA3347627
Max Phase: Preclinical
Molecular Formula: C42H50BN5O5
Molecular Weight: 715.70
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)c1cnccn1)B1O[C@@H]2[C@H]3CC[C@H](C3(C)C)[C@]2(C)O1
Standard InChI: InChI=1S/C42H50BN5O5/c1-26(2)21-36(43-52-37-31-17-18-35(41(31,3)4)42(37,5)53-43)48-39(50)32(23-27-11-7-6-8-12-27)46-38(49)33(47-40(51)34-25-44-19-20-45-34)24-28-15-16-29-13-9-10-14-30(29)22-28/h6-16,19-20,22,25-26,31-33,35-37H,17-18,21,23-24H2,1-5H3,(H,46,49)(H,47,51)(H,48,50)/t31-,32+,33+,35-,36+,37-,42+/m1/s1
Standard InChI Key: UCRIGFMMGLHGLL-WXCTUJBXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 715.70 | Molecular Weight (Monoisotopic): 715.3905 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Trippier PC, McGuigan C. (2010) Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications, 1 (3): [10.1039/C0MD00119H] |
Source(1):